|
“Nano-flares” for the Analysis of Circulating Cancer Cells Chad A. Mirkin, 博士,现担任巴拉克•奥巴马总统的科学与技术顾问委员会委员,国际纳米技术研究所主任,美国西北大学化学系George B. Rathmann教授,化工与生物工程系教授,生物医学工程系教授,材料科学与工程系教授,医学系教授。 Dr. Chad A. Mirkin, Director of the International Institute for Nanotechnology, the George B. Rathmann Professor of Chemistry, Professor of Chemical and Biological Engineering, Professor of Biomedical Engineering, Professor of Materials Science & Engineering, and Professor of Medicine,Northwestern University |
|
Icotinib, the First Target Therapeutic Drug for Cancer in China 王印祥博士,浙江贝达药业有限公司总裁,首席科学家。2003年开始在北京筹建贝达药业新药研发中心,包括药物合成研究室、药理研究室、药物制剂研究室、药物分析研究室、药物申报注册室、知识产权部和医学部等。立项并指导民埃克替尼和数个一类新药的研究和上市。 Dr. Yinxiang Wang is the CEO and Chief Scientist Officer (CSO) of Zhejiang Beta Pharma, Inc. (ZBPI).As the CSO and one of the main innovators at ZBPI, Dr. Wang headed the research team which developed Icotinib Hydrochloride (Conmana®), a National Category-1 Novel Drug (NME). He was the project leader in charge of the pre-clinical and clinical phase I-III studies of Icotinib Hydrochloride as well as the commercialization of Icotinib. |
Huanqin Dai, Ph.D.Assistant Professor ,Institute of Microbiology, Chinese Academy of Sciences
Ruibao Ren, Ph.D. Deputy Director Shanghai Institute of Hematology
Gil Alterovitz Ph.D.Assistant Professor Harvard Medical School
Haian Fu, PhDDirector of Emory Chemical Biology Discovery Center, Emory University
Rudi Bao, Ph.D.Biology VP Hansoh Pharmaceuticals Group
Shutao Wang Ph.D.Professor of Chemistry , Institute of Chemistry Chinese Academy of Sciences
Peng Liu Ph.D.Professor , Department of Biomedical Engineering, Tsinghua University
Chengbin Wu Ph.D.VP of Biologics ChemPartner
Zhuyin (Julie) Li Ph. D.Biology Team Leader, National Center for Advancing Translational Sciences; NIH, USA
Yao Chang Xu Ph.D.General manager of Hansoh Pharmaceutical Group
Cai Li, Ph.D.Director and In Vivo Pharmacology China Lead of Merck Research Laboratories
Joergen Nielsen, Ph.D.Principal Scientist , Assay Development and HTS, F. Hoffmann – La Roche, Basel, Switzerland
Qihui Shi, Ph.D.Professor ,Shanghai Jiao Tong University
Chaoyong Yang, Ph.D.Professor ,Department of Chemical Biology, Xiamen University
Jia-Ning Xiang, Ph.D.Head of Integrated Platform Science GlaxoSmithKline R&D China
Shuyi Si, Ph.D.Director of National Center of Screening for New Microbial Drugs
Xu Lin, Ph.D.Professor Institute for Nutritional Sciences
Bin Peng, Ph.D.Global Head (Executive Director) Oncology Translational Medicine (OTM) China, Novartis
Darren R. Link,Ph.D.Cofounder and Vice President, of Research & Development RainDance Technologies, Inc.
Paul Tewson, Ph.D. Research Assiocate, of Montana Molecular
Jonathan H Connick, Ph.D.Executive Director and Chair in vitro Pharmacology Council, Merck & Co.
Andrea Weston,Ph.D.Senior Research Investigator Cellular Systems Group
Marcie Glicksman, Ph.D.Co-Director of Laboratory for Drug Discovery in Neurodegeneration
主办单位 / Host
热点新闻 / Hot News
SLAS社交媒体 / Follow Us
注册热线 / Registration Hotline
+86 21 5108-1556
版权所有 / Copyright